UNSPSC 51283702: Cefamandole

This classification denotes a cephalosporin antibiotic with the molecular formula C18H18N6O5S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5CKP8C2LLI, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((hydroxyphenylacetyl)amino)-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r-(6alpha,7beta(r*)))- but generally known as cefamandole, which bears US NIH Compound Identifier 36831.

UNSPSC 51283702 Cefamandole, a Commodity code, encompasses pharmaceutical products and medical supplies procured by state and local health agencies, though recent opportunities tagged under this code show a mismatch with its narrow product scope. State and local governments issuing solicitations in this category include county health departments, state health and human services commissions, city fire and rescue divisions, and multistate cooperative purchasing alliances. The work spans acquisition of specific pharmaceuticals, naloxone and drug deactivation systems for community health programs, medical and first aid supplies for emergency response, and participation in broader generic multi-source pharmaceutical programs serving government facilities. Issuing bodies range from individual county health departments to statewide cooperative purchasing vehicles like the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), which consolidates procurement across participating jurisdictions.

Recent activity appears concentrated in Florida and Minnesota, with Texas representing emerging demand through exploratory information-gathering. Representative recent opportunities include Seminole County, Florida's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000.00 and sheltered as a small local business enterprise set-aside with a 5 percent bid discount; and MMCAP's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon. The Texas Health and Human Services Commission also issued RFI HHS0017013 (posted April 3, 2026) to explore direct-to-manufacturer prescription programs, signaling potential future demand.